Paul Knoebl

4.5k total citations · 1 hit paper
81 papers, 2.8k citations indexed

About

Paul Knoebl is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Paul Knoebl has authored 81 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 30 papers in Genetics and 25 papers in Immunology. Recurrent topics in Paul Knoebl's work include Hemophilia Treatment and Research (28 papers), Platelet Disorders and Treatments (26 papers) and Complement system in diseases (25 papers). Paul Knoebl is often cited by papers focused on Hemophilia Treatment and Research (28 papers), Platelet Disorders and Treatments (26 papers) and Complement system in diseases (25 papers). Paul Knoebl collaborates with scholars based in Austria, United Kingdom and France. Paul Knoebl's co-authors include Peter W. Collins, F. Baudo, Angela Huth‐Kühne, László Nemes, Lilian Tengborn, Fabio Pellegrini, Pascual Marco, H. Lévesque, Andreas Tiede and Craig M. Kessler and has published in prestigious journals such as Blood, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Paul Knoebl

68 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International recommendations on the diagnosis and treatment of acquired hemophilia A

2020 183 citations Andreas Tiede, Peter W. Collins et al. profile →

Peers

Paul Knoebl

HEMAT

GENET

IMMUN

SURGE

Angel de Francisco Spain

Hiroyasu Yamamoto Japan

Lona Poole United States

Paul R. J. Ames United Kingdom

Franco Manzato Italy

Gemino Fiorelli Italy

Peter Kubisz Slovakia

Danyelle Romana Alves Rios Brazil

Michael Desborough United Kingdom

Moglie Le Quintrec France

Angel de Francisco Spain

Paul Knoebl

500 ×0.2

HEMAT

204 ×0.2

GENET

100 ×0.3

IMMUN

162 ×0.8

SURGE

157 ×0.8

Citations per year, relative to Paul Knoebl Paul Knoebl (= 1×) peers Angel de Francisco

Countries citing papers authored by Paul Knoebl

Since Specialization

Citations

This map shows the geographic impact of Paul Knoebl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Knoebl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Knoebl more than expected).

Fields of papers citing papers by Paul Knoebl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Knoebl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Knoebl. The network helps show where Paul Knoebl may publish in the future.

Co-authorship network of co-authors of Paul Knoebl

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Knoebl. A scholar is included among the top collaborators of Paul Knoebl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Knoebl. Paul Knoebl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dobbelstein, Christiane, Robert Klamroth, Christina Hart, et al.. (2025). Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A. Blood Advances. 9(22). 5853–5860.

Scully, Marie, Spero R. Cataland, Paul Coppo, et al.. (2025). Novel von willebrand factor targeting thrombolytic TGD001 is safe and well tolerated in a phase 1 first-in-human trial. Blood. 146(Supplement 1). 849–849.

Tran, Huyen, Sylvia von Mackensen, Aby Abraham, et al.. (2024). Concizumab prophylaxis in persons with hemophilia A or B with inhibitors: patient-reported outcome results from the phase 3 explorer7 study. Research and Practice in Thrombosis and Haemostasis. 8(4). 102476–102476. 6 indexed citations

Thaler, J., Carla Tripisciano, Chi M. Hau, et al.. (2024). Saliva of persons with hemophilia A triggers coagulation via extrinsic tenase complexes. Blood. 144(25). 2666–2677.

Wendt, Ralph, Linus A. Völker, Martin Bommer, et al.. (2024). 100 Jahre Thrombotisch-thrombozytopenische Purpura (TTP) – Was haben wir gelernt?. DMW - Deutsche Medizinische Wochenschrift. 149(23). 1423–1430.

Kühne, Lucas, et al.. (2023). Management of Immune Thrombotic Thrombocytopenic Purpura without Therapeutic Plasma Exchange: Analysis of Efficacy and Safety Data. Blood. 142(Supplement 1). 4001–4001. 1 indexed citations

Pfrepper, Christian, Robert Klamroth, Johannes Oldenburg, et al.. (2023). Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group. Hämostaseologie. 44(6). 466–471. 10 indexed citations

Greiner, Georg, Rodrig Marculescu, Karoline V. Gleixner, et al.. (2023). N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia. American Journal of Hematology. 98(2). 290–299. 5 indexed citations

Coppo, Paul, Parth Patwari, Björn Mellgård, et al.. (2023). OC 14.4 Recombinant ADAMTS13 Prophylaxis in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Interim Analysis from Phase 3B Continuation Study. Research and Practice in Thrombosis and Haemostasis. 7. 100534–100534. 2 indexed citations

10.

Peyvandi, Flora, Spero R. Cataland, Marie Scully, et al.. (2021). Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood Advances. 5(8). 2137–2141. 50 indexed citations

11.

Cuker, Adam, Spero R. Cataland, Paul Coppo, et al.. (2021). Redefining outcomes in immune TTP: an international working group consensus report. Blood. 137(14). 1855–1861. 121 indexed citations

12.

Azoulay, Élie, Paul Knoebl, José Garnacho‐Montero, et al.. (2017). Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome. CHEST Journal. 152(2). 424–434. 36 indexed citations

13.

Knoebl, Paul, Pascual Marco, F. Baudo, et al.. (2012). Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Journal of Thrombosis and Haemostasis. 10(4). 622–631. 326 indexed citations

14.

Tengborn, Lilian, F. Baudo, Angela Huth‐Kühne, et al.. (2012). Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG An International Journal of Obstetrics & Gynaecology. 119(12). 1529–1537. 81 indexed citations

15.

Knoebl, Paul. (2010). Blood coagulation disorders in septic patients. Wiener Medizinische Wochenschrift. 160(5-6). 129–138. 18 indexed citations

16.

Knoebl, Paul. (2008). Human protein C concentrates for replacement therapy in congenitaland acquired protein C deficiency. Drugs of today. 44(6). 429–429. 8 indexed citations

17.

Rabitsch, Werner, Thomas Staudinger, Gottfried J. Locker, et al.. (2005). Respiratory failure after stem cell transplantation: Improved outcome with non-invasive ventilation. Leukemia & lymphoma. 46(8). 1151–1157. 12 indexed citations

18.

Bergler‐Klein, Jutta, Paul Knoebl, Berthold Streubel, et al.. (2003). Myocardial involvement in a patient with Burkitt's lymphoma mimicking hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography. 16(12). 1326–1330. 7 indexed citations

19.

Locker, Gottfried J., Michael Grimm, Heidrun Losert, et al.. (2000). Prostaglandin E1 does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting. Journal of Clinical Anesthesia. 12(5). 363–370. 3 indexed citations

20.

Thalhammer-Scherrer, Renate, Georg Wieselthaler, Paul Knoebl, et al.. (1999). Post-transplant acute myeloid leukemia (PT-AML). Leukemia. 13(3). 321–326. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact